| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO and Secretary | Common Stock | 14,565 | $4,694,008 | $322.28 | 02 Mar 2026 | Direct |
| ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO and Secretary | Stock Option (right to buy) | 3,381 | 02 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 02 Mar 2026 | 2 | $0 | 4 | EVP, CLO and Secretary | 04 Mar 2026, 19:29 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 01 Oct 2025 | 1 | $0 | 4 | EVP, CLO and Secretary | 03 Oct 2025, 17:15 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 15 Sep 2025 | 0 | $0 | 3 | EVP, CLO and Secretary | 22 Sep 2025, 16:04 |